ATEN stock · BIO stock

ATEN vs BIO · P/E 50, rev $155.1M vs rev $651.0M

A10 Network (ATEN) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.

A10 Network (ATEN) is a software - infrastructure company listed on US.

BIO (BIO) common stock.

Latest reported ATEN revenue for 2026-06-30 was $155.1M. Net income was $20.9M. ATEN currently screens at market cap $2.20B and trailing P/E 50.1.

Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.

ATEN currently screens at market cap $2.20B and trailing P/E 50.1. BIO currently screens at market cap $0.

Not investment advice. Open the ATEN and BIO stock pages for the full models.

Not investment advice.

Popular Stock Comparisons